Web Results
Walgreens  
(18)
20321 Susan Leslie Dr
(703) 726-8647
CVS  
(51)
43930 Farmwell Hunt Plz
(703) 724-7582
(22)
20070 Ashbrook Commons Plz
(571) 223-0110
Walgreens  
(16)
43250 Southern Walk Plz
(703) 729-0693
Source:

academic.oup.com/rpc/article/125/8/631/1610054

Jun 28, 2008 ... Actavis Uk Ltd v Merck & Co Inc ..... After Jeyes' patent [i.e. the prior art] it was open to all the world to make and sell such a material. ..... was mode of administration (T 51/93 SERONO (unpublished)). ..... in the manufacture of taxol; but the mixing in the hospital pharmacy of taxol ..... They are Thigpen et ors.

www.law360.com/articles/1016361/jury-sides-with-pfizer-serono-in-biogen-s-ip-spat

Feb 26, 2018 ... The jury found that EMD Serono Inc. and Pfizer Inc. directly infringed and contributed to direct infringement of Biogen Inc.'s U.S. Patent Number ...

www.law360.com/articles/172411/biogen-sues-bayer-others-over-multiple-sclerosis-drug

Jun 2, 2010 ... The cases are Biogen Idec MA Inc. v. EMD Serono et al., case number 10-cv- 02760, and Bayer Healthcare Pharmaceuticals Inc. v. Biogen Idec ...

www.emdserono.com/us-en/expertise.html

... devices for a number of our therapies, as well as comprehensive support services and patient education resources across all of our therapeutic areas of focus.

www.amcp.org/EMDSeronoSpecialtyDigest9th.pdf

Message from James E. Hoyes, President, EMD Serono, Inc. ... with health care organizations and specialty pharmacies to develop mutually effective ... priority for health plans related to specialty pharmaceutical management. ..... Blaser DA, Lewtas AJ, et al. .... unique cost share for specialty drugs vs. non-specialty drugs.

www.amcp.org/WorkArea/DownloadAsset.aspx?id=15229

Serono Specialty Digest™ was developed by Rxperts, Inc., and was reviewed and approved by ... Gleason, et al, analyzed the relationship between prescription.

www.amcp.org/WorkArea/DownloadAsset.aspx?id=17840

Apr 3, 2014 ... The Sax et al. probability of hospitalization if adherence was ≥ 95% was 0.072 per ...... D. PFS and OS for V were assumed to be the same as with D. QALY weights ...... SPONSORSHiP: This research was funded by EMD Serono, Inc. E2Trends of ...... Specialty Pharmacy papers will be given priority review.

www.acludc.org/sites/default/files/field_documents/nfprha_v_dept_of_hhs_-_motion_for_preliminary_injunction.pdf

May 8, 2018 ... Planned Parenthood of Wisconsin, Inc., Planned Parenthood of Greater .... HHS's “Program Priorities” and “Key Issues” contradict Title X's ..... Serono Laboratories, Inc. v. ..... Carter, Marion W. et al., Four aspects of the scope and quality of ...... 7, 2012) (recognizing irreparable injury where a pharmacy was ...

www1.magellanrx.com/media/505016/summer-2016_final.pdf

Sep 10, 2016 ... supportive care vs therapeutic • .... HealthCore Inc., specialty pharmacy costs per member increased .... Priority Health initially launched a Medication Therapy Management (MTM) pilot ..... patients.12 In a study performed by Arikian et al., it was ...... commercial health plans participating in the EMD Serono.